{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:22:10Z","timestamp":1785529330034,"version":"3.56.0"},"reference-count":49,"publisher":"Wiley","issue":"19","license":[{"start":{"date-parts":[[2007,9,24]],"date-time":"2007-09-24T00:00:00Z","timestamp":1190592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The FEBS Journal"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:p>Protein misfolding is recognized as an important pathophysiological cause of protein deficiency in many genetic disorders. Inherited mutations can disrupt native protein folding, thereby producing proteins with misfolded conformations. These misfolded proteins are consequently retained and degraded by endoplasmic reticulum\u2010associated degradation, although they would otherwise be catalytically fully or partially active. Active\u2010site directed competitive inhibitors are often effective active\u2010site\u2010specific chaperones when they are used at subinhibitory concentrations. Active\u2010site\u2010specific chaperones act as a folding template in the endoplasmic reticulum to facilitate folding of mutant proteins, thereby accelerating their smooth escape from the endoplasmic reticulum\u2010associated degradation to maintain a higher level of residual enzyme activity. In Fabry disease, degradation of mutant lysosomal \u03b1\u2010galactosidase\u2003A caused by a large set of missense mutations was demonstrated to occur within the endoplasmic reticulum\u2010associated degradation as a result of the misfolding of mutant proteins. 1\u2010Deoxygalactonojirimycin is one of the most potent inhibitors of \u03b1\u2010galactosidase\u2003A. It has also been shown to be the most effective active\u2010site\u2010specific chaperone at increasing residual enzyme activity in cultured fibroblasts and lymphoblasts established from Fabry patients with a variety of missense mutations. Oral administration of 1\u2010deoxygalactonojirimycin to transgenic mice expressing human R301Q \u03b1\u2010galactosidase\u2003A yielded higher \u03b1\u2010galactosidase\u2003A activity in major tissues. These results indicate that 1\u2010deoxygalactonojirimycin could be of therapeutic benefit to Fabry patients with a variety of missense mutations, and that the active\u2010site\u2010specific chaperone approach using functional small molecules may be broadly applicable to other lysosomal storage disorders and other protein deficiencies.<\/jats:p>","DOI":"10.1111\/j.1742-4658.2007.06041.x","type":"journal-article","created":{"date-parts":[[2007,9,24]],"date-time":"2007-09-24T17:43:13Z","timestamp":1190655793000},"page":"4962-4971","source":"Crossref","is-referenced-by-count":106,"title":["Active\u2010site\u2010specific chaperone therapy for Fabry disease"],"prefix":"10.1111","volume":"274","author":[{"given":"Jian\u2010Qiang","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,9,24]]},"reference":[{"key":"e_1_2_12_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196705252762101"},{"key":"e_1_2_12_3_2","doi-asserted-by":"publisher","DOI":"10.1006\/rwgn.2001.0443"},{"key":"e_1_2_12_4_2","first-page":"71A","article-title":"Fabry disease: an asymptomatic hemizygote with significant residual \u03b1\u2010galactosidase A activity","volume":"33","author":"Bishop DF","year":"1981","journal-title":"Am J Hum Genet"},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508033330504"},{"key":"e_1_2_12_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00160.x"},{"key":"e_1_2_12_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2005.tb02103.x"},{"key":"e_1_2_12_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000016683.73778.78"},{"key":"e_1_2_12_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-4-200302180-00014"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000012626.81324.38"},{"key":"e_1_2_12_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000085709"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2005.tb02119.x"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450102"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2743"},{"key":"e_1_2_12_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2005.04.009"},{"key":"e_1_2_12_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2003.00831.x"},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550410030682"},{"key":"e_1_2_12_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2004.00284.x"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/4801"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(03)00158-5"},{"key":"e_1_2_12_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192582899"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2006.05410.x"},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M308523200"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2536657100"},{"key":"e_1_2_12_25_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0404764101"},{"key":"e_1_2_12_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2004.00232.x"},{"key":"e_1_2_12_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2004.08.001"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.13.4859"},{"key":"e_1_2_12_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2004.01.035"},{"key":"e_1_2_12_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-7192(02)00151-8"},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.2659"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.2000.1743"},{"key":"e_1_2_12_33_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20070479"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1052"},{"key":"e_1_2_12_35_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.73.011303.073752"},{"key":"e_1_2_12_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812033392307"},{"key":"e_1_2_12_37_2","first-page":"5121","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Welsh MJ","year":"2001"},{"key":"e_1_2_12_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00484919"},{"key":"e_1_2_12_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)61618-7"},{"key":"e_1_2_12_40_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.0486"},{"key":"e_1_2_12_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01457.x"},{"key":"e_1_2_12_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(03)01069-3"},{"key":"e_1_2_12_43_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-2375com"},{"key":"e_1_2_12_44_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00426.2005"},{"key":"e_1_2_12_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.05.082"},{"key":"e_1_2_12_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/35008096"},{"key":"e_1_2_12_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/21.7.1628"},{"key":"e_1_2_12_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2004.07.001"},{"key":"e_1_2_12_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107053450104"},{"key":"e_1_2_12_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00219337"}],"container-title":["The FEBS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-4658.2007.06041.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-4658.2007.06041.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:36:12Z","timestamp":1697502972000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-4658.2007.06041.x"}},"subtitle":["Yin and Yang of enzyme inhibitors"],"short-title":[],"issued":{"date-parts":[[2007,9,24]]},"references-count":49,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1742-4658.2007.06041.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-4658.2007.06041.x","archive":["Portico"],"relation":{},"ISSN":["1742-464X","1742-4658"],"issn-type":[{"value":"1742-464X","type":"print"},{"value":"1742-4658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,24]]}}}